Principal Financial Group Inc Akero Therapeutics, Inc. Transaction History
Principal Financial Group Inc
- $167 Billion
- Q1 2025
A detailed history of Principal Financial Group Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 257,025 shares of AKRO stock, worth $11.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
257,025Holding current value
$11.7 Million% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding AKRO
# of Institutions
214Shares Held
67.4MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$313 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$275 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$255 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$239 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$197 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.12B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...